Exact Mass: 486.2087546000001
Exact Mass Matches: 486.2087546000001
Found 191 metabolites which its exact mass value is equals to given mass value 486.2087546000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside is from Fusarium sulphureu From Fusarium sulphureum
Glucosylgalactosyl hydroxylysine
Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences. The hydroxylysine residues formed in the lysyl hydroxylase reaction have 2 important functions: first, their hydroxy groups serve as sites of attachment for carbohydrate units, either the monosaccharide galactose or the disaccharide glucosylgalactose; and second, they are essential for the stability of the intermolecular collagen crosslinks. (OMIM 153454). Hydroxylysine-deficient skin collagen is manifested in Ehlers-Danlos syndrome, type VIA, A heritable disorder of connective tissue (PMID 5016372). Glucosylgalactosyl hydroxylysine is a Glycoside of hydroxylysine. Hydroxylation of lysine is an important post-translational modification of collagen, (PMID 10928217) a reaction catalyzed by the enzyme Lysyl hydroxylase (EC 1.14.11.4) forming hydroxylysine in collagens and other proteins with collagen-like amino acid sequences, by the hydroxylation of lysine residues in X-lys-gly sequences.
2-O-alpha-D-Glucopyranosyl-O-beta-D-galactopyranosylhydroxylysine
Antibiotic LL-AB 664
C18H30N8O8 (486.21864999999997)
N-(4-Cyanophenyl)-2-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)phenoxy]acetamide
C26H26N6O4 (486.20154360000004)
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
Catharanthine tartrate
C21H24N2O2.C4H6O6 (486.200206)
4-[6-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3-methyl-2-oxohexyl]dihydro-3-methylene-5-(2-oxopropyl)-2(3H)-furanone
Artelastochromene
2-{O3-carbamoyl-2-[(N-formimidoyl-glycyl)-methyl-amino]-beta-D-2-deoxy-gulopyranosylamino}-7-hydroxy-5-methyl-1(3),3a,5,6,7,7a-hexahydro-imidazo[4,5-c]pyridin-4-one
C18H30N8O8 (486.21864999999997)
6-O-(4-methoxybenzoyl)crescentin IV 3-O-beta-D-glucopyranoside
1-(4-beta-D-glucopyranosyloxybenzyl) 4-ethyl (2R)-2-isobutylmalate
Catharanthine tartrate
Ala Ala Tyr Tyr
Ala Phe Ser Tyr
Ala Phe Tyr Ser
Ala Ser Phe Tyr
Ala Ser Tyr Phe
Ala Tyr Ala Tyr
Ala Tyr Phe Ser
Ala Tyr Ser Phe
Ala Tyr Tyr Ala
Asp Pro Gln Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Pro Gln
C19H30N6O9 (486.20741699999996)
Asp Gln Gln Pro
C19H30N6O9 (486.20741699999996)
Glu His Thr Thr
C19H30N6O9 (486.20741699999996)
Glu Asn Pro Gln
C19H30N6O9 (486.20741699999996)
Glu Asn Gln Pro
C19H30N6O9 (486.20741699999996)
Glu Pro Asn Gln
C19H30N6O9 (486.20741699999996)
Glu Pro Gln Asn
C19H30N6O9 (486.20741699999996)
Glu Gln Asn Pro
C19H30N6O9 (486.20741699999996)
Glu Gln Pro Asn
C19H30N6O9 (486.20741699999996)
Glu Thr His Thr
C19H30N6O9 (486.20741699999996)
Glu Thr Thr His
C19H30N6O9 (486.20741699999996)
Phe Ala Ser Tyr
Phe Ala Tyr Ser
Phe Phe Ser Ser
Phe Gly Thr Tyr
Phe Gly Tyr Thr
Phe Ser Ala Tyr
Phe Ser Phe Ser
Phe Ser Ser Phe
Phe Ser Tyr Ala
Phe Thr Gly Tyr
Phe Thr Tyr Gly
Phe Tyr Ala Ser
Phe Tyr Gly Thr
Phe Tyr Ser Ala
Phe Tyr Thr Gly
Gly Phe Thr Tyr
Gly Phe Tyr Thr
Gly His His His
C20H26N10O5 (486.2087546000001)
Gly Thr Phe Tyr
Gly Thr Tyr Phe
Gly Tyr Phe Thr
Gly Tyr Thr Phe
His Glu Thr Thr
C19H30N6O9 (486.20741699999996)
His Gly His His
C20H26N10O5 (486.2087546000001)
His His Gly His
C20H26N10O5 (486.2087546000001)
His His His Gly
C20H26N10O5 (486.2087546000001)
His Thr Glu Thr
C19H30N6O9 (486.20741699999996)
His Thr Thr Glu
C19H30N6O9 (486.20741699999996)
Asn Glu Pro Gln
C19H30N6O9 (486.20741699999996)
Asn Glu Gln Pro
C19H30N6O9 (486.20741699999996)
Asn Pro Glu Gln
C19H30N6O9 (486.20741699999996)
Asn Pro Gln Glu
C19H30N6O9 (486.20741699999996)
Asn Gln Glu Pro
C19H30N6O9 (486.20741699999996)
Asn Gln Pro Glu
C19H30N6O9 (486.20741699999996)
Pro Asp Gln Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Asn Gln
C19H30N6O9 (486.20741699999996)
Pro Glu Gln Asn
C19H30N6O9 (486.20741699999996)
Pro Asn Glu Gln
C19H30N6O9 (486.20741699999996)
Pro Asn Gln Glu
C19H30N6O9 (486.20741699999996)
Pro Gln Asp Gln
C19H30N6O9 (486.20741699999996)
Pro Gln Glu Asn
C19H30N6O9 (486.20741699999996)
Pro Gln Asn Glu
C19H30N6O9 (486.20741699999996)
Pro Gln Gln Asp
C19H30N6O9 (486.20741699999996)
Gln Asp Pro Gln
C19H30N6O9 (486.20741699999996)
Gln Asp Gln Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Asn Pro
C19H30N6O9 (486.20741699999996)
Gln Glu Pro Asn
C19H30N6O9 (486.20741699999996)
Gln Asn Glu Pro
C19H30N6O9 (486.20741699999996)
Gln Asn Pro Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Asp Gln
C19H30N6O9 (486.20741699999996)
Gln Pro Glu Asn
C19H30N6O9 (486.20741699999996)
Gln Pro Asn Glu
C19H30N6O9 (486.20741699999996)
Gln Pro Gln Asp
C19H30N6O9 (486.20741699999996)
Gln Gln Asp Pro
C19H30N6O9 (486.20741699999996)
Gln Gln Pro Asp
C19H30N6O9 (486.20741699999996)
Ser Ala Phe Tyr
Ser Ala Tyr Phe
Ser Phe Ala Tyr
Ser Phe Phe Ser
Ser Phe Ser Phe
Ser Phe Tyr Ala
Ser Ser Phe Phe
Ser Tyr Ala Phe
Ser Tyr Phe Ala
Thr Glu His Thr
C19H30N6O9 (486.20741699999996)
Thr Glu Thr His
C19H30N6O9 (486.20741699999996)
Thr Phe Gly Tyr
Thr Phe Tyr Gly
Thr Gly Phe Tyr
Thr Gly Tyr Phe
Thr His Glu Thr
C19H30N6O9 (486.20741699999996)
Thr His Thr Glu
C19H30N6O9 (486.20741699999996)
Thr Thr Glu His
C19H30N6O9 (486.20741699999996)
Thr Thr His Glu
C19H30N6O9 (486.20741699999996)
Thr Tyr Phe Gly
Thr Tyr Gly Phe
Tyr Ala Ala Tyr
Tyr Ala Phe Ser
Tyr Ala Ser Phe
Tyr Ala Tyr Ala
Tyr Phe Ala Ser
Tyr Phe Gly Thr
Tyr Phe Ser Ala
Tyr Phe Thr Gly
Tyr Gly Phe Thr
Tyr Gly Thr Phe
Tyr Ser Ala Phe
Tyr Ser Phe Ala
Tyr Thr Phe Gly
Tyr Thr Gly Phe
Tyr Tyr Ala Ala
15-Acetoxyscirpene-3,4-diol 4-O-a-D-glucopyranoside
N^a-Boc-N^w-(4-Methoxy-2,3,6-triMethylphenylsulfonyl)-D-arginine
C21H34N4O7S (486.21480940000004)
N-(4-(phenyl-9H-carbazol-3-yl)phenyl)biphenyl-4-aMine
[5-[[2-(aminomethylideneamino)acetyl]-methylamino]-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-5-methyl-4-oxo-3a,6,7,7a-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate
C18H30N8O8 (486.21864999999997)
3-deamino-3-hydroxykanamycin X
A kanamycin that is kanamycin X in which the 3-amino group has been replaced by a hydroxy group.
[(1S,2R,9R,10R,11S)-10-Hydroxy-1,5-dimethyl-11-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
(1R,9S,10S,11S)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
(1S,9R,10R,11R)-12-N-(2,5-difluorophenyl)-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-11-N-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11,12-dicarboxamide
4-Ethoxycarbonyl-3-[3-(ethylamino)-6-ethylimino-2,7-dimethylxanthen-9-yl]benzoic acid
MRS 1754
C26H26N6O4 (486.20154360000004)
MRS 1754 is a selective antagonist radioligand for A2B adenosine receptor with very low affinity for A1 and A3 receptors of both humans and rats[1].
5-[(alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy]-L-lysine
An O-glycosyl amino acid that is L-lysine in which one of the methylene hydrogens at position 5 has been replaced by an (alpha-D-glucopyranosyl-(1->2)-beta-D-galactopyranosyl)oxy group.
Catharanthine (Tartrate)
Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1]. Catharanthine Tartrate is an alkaloid isolated from Catharanthus roseus, inhibits voltage-operated L-type Ca2+ channel, with anti-cancer and blood pressure-lowering activity[1].
TAN-452
TAN-452 is an orally active, selective peripherally acting δ-opioid receptor (DOR) antagonist with a Ki of 0.47?nM and a Kb of 0.21?nM. TAN-452 is an antagonist for μ-opioid receptor (MOR; Ki=36.56?nM and Kb=9.43?nM) and κ-opioid receptor (KOR; Ki=5.31?nM and Kb=7.18?nM). TAN-452, a derivative of Naltrindole, demonstrates low brain penetrability and attenuates morphine-induced side effects without affecting pain control[1].